Drägerwerk AG & Co. KGaA (DRW8) - Net Assets
Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DRW8) has net assets worth €1.51 Billion EUR (≈ $1.76 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.03 Billion ≈ $3.54 Billion USD) and total liabilities (€1.52 Billion ≈ $1.78 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Drägerwerk AG & Co. KGaA (DRW8) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.51 Billion |
| % of Total Assets | 49.8% |
| Annual Growth Rate | 9.85% |
| 5-Year Change | 48.65% |
| 10-Year Change | 62.46% |
| Growth Volatility | 27.8 |
Drägerwerk AG & Co. KGaA - Net Assets Trend (2005–2024)
This chart illustrates how Drägerwerk AG & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Also explore Drägerwerk AG & Co. KGaA (DRW8) total assets for the complete picture of this company's asset base.
Annual Net Assets for Drägerwerk AG & Co. KGaA (2005–2024)
The table below shows the annual net assets of Drägerwerk AG & Co. KGaA from 2005 to 2024. For live valuation and market cap data, see DRW8 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.54 Billion ≈ $1.80 Billion |
+9.05% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
+6.81% |
| 2022-12-31 | €1.32 Billion ≈ $1.54 Billion |
+4.68% |
| 2021-12-31 | €1.26 Billion ≈ $1.47 Billion |
+21.93% |
| 2020-12-31 | €1.03 Billion ≈ $1.21 Billion |
-3.95% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
-0.40% |
| 2018-12-31 | €1.08 Billion ≈ $1.26 Billion |
+1.15% |
| 2017-12-31 | €1.07 Billion ≈ $1.25 Billion |
+6.46% |
| 2016-12-31 | €1.00 Billion ≈ $1.17 Billion |
+6.09% |
| 2015-12-31 | €945.93 Million ≈ $1.11 Billion |
+5.50% |
| 2014-12-31 | €896.61 Million ≈ $1.05 Billion |
+9.88% |
| 2013-12-31 | €815.97 Million ≈ $953.95 Million |
+12.21% |
| 2012-12-31 | €727.20 Million ≈ $850.17 Million |
-0.33% |
| 2011-12-31 | €729.62 Million ≈ $853.00 Million |
+14.62% |
| 2010-12-31 | €636.56 Million ≈ $744.21 Million |
+61.64% |
| 2009-12-31 | €393.82 Million ≈ $460.42 Million |
-23.92% |
| 2008-12-31 | €517.64 Million ≈ $605.18 Million |
+2.40% |
| 2007-12-31 | €505.49 Million ≈ $590.97 Million |
-6.39% |
| 2006-12-31 | €539.99 Million ≈ $631.31 Million |
+109.56% |
| 2005-12-31 | €257.68 Million ≈ $301.25 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Drägerwerk AG & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3111.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.18 Billion | 77.15% |
| Common Stock | €48.03 Million | 3.13% |
| Other Comprehensive Income | €-2.61 Million | -0.17% |
| Other Components | €305.36 Million | 19.89% |
| Total Equity | €1.54 Billion | 100.00% |
Drägerwerk AG & Co. KGaA Competitors by Market Cap
The table below lists competitors of Drägerwerk AG & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VITZROCELL Co.Ltd
KQ:082920
|
$831.88 Million |
|
Guangzhou KingTeller Technology Co Ltd
SHE:002177
|
$832.06 Million |
|
Global Top E Commerce Co Ltd
SHE:002640
|
$832.17 Million |
|
Shenzhen Sunxing Light Alloys
SHG:603978
|
$832.17 Million |
|
Prima Andalan Mandiri Tbk PT
JK:MCOL
|
$831.28 Million |
|
STEVANATO GROUP SPA O.N.
F:87N
|
$831.06 Million |
|
Zhejiang Shengyang Science
SHG:603703
|
$830.72 Million |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
$830.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Drägerwerk AG & Co. KGaA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,406,779,000 to 1,535,151,000, a change of 128,372,000 (9.1%).
- Net income of 124,408,000 contributed positively to equity growth.
- Dividend payments of 33,158,000 reduced retained earnings.
- Share repurchases of 2,535,000 reduced equity.
- Other comprehensive income increased equity by 16,956,001.
- Other factors increased equity by 22,700,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €124.41 Million | +8.1% |
| Dividends Paid | €33.16 Million | -2.16% |
| Share Repurchases | €2.54 Million | -0.17% |
| Other Comprehensive Income | €16.96 Million | +1.1% |
| Other Changes | €22.70 Million | +1.48% |
| Total Change | €- | 9.13% |
Book Value vs Market Value Analysis
This analysis compares Drägerwerk AG & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.86x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.70x to 0.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | €18.93 | €70.00 | x |
| 2006-12-31 | €22.53 | €70.00 | x |
| 2007-12-31 | €25.46 | €70.00 | x |
| 2008-12-31 | €26.31 | €70.00 | x |
| 2009-12-31 | €29.78 | €70.00 | x |
| 2010-12-31 | €43.06 | €70.00 | x |
| 2011-12-31 | €43.47 | €70.00 | x |
| 2012-12-31 | €43.04 | €70.00 | x |
| 2013-12-31 | €47.94 | €70.00 | x |
| 2014-12-31 | €52.73 | €70.00 | x |
| 2015-12-31 | €53.61 | €70.00 | x |
| 2016-12-31 | €56.39 | €70.00 | x |
| 2017-12-31 | €60.08 | €70.00 | x |
| 2018-12-31 | €60.77 | €70.00 | x |
| 2019-12-31 | €60.52 | €70.00 | x |
| 2020-12-31 | €55.97 | €70.00 | x |
| 2021-12-31 | €67.16 | €70.00 | x |
| 2022-12-31 | €70.26 | €70.00 | x |
| 2023-12-31 | €74.99 | €70.00 | x |
| 2024-12-31 | €81.83 | €70.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Drägerwerk AG & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.10%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.69%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 2.02x
- Recent ROE (8.10%) is below the historical average (10.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 17.05% | 2.69% | 1.06x | 5.96x | €18.18 Million |
| 2006 | 15.13% | 2.42% | 1.10x | 5.67x | €14.81 Million |
| 2007 | 14.14% | 2.54% | 1.11x | 5.02x | €13.51 Million |
| 2008 | 9.60% | 1.69% | 1.16x | 4.89x | €-1.34 Million |
| 2009 | 8.34% | 1.70% | 1.01x | 4.84x | €-6.47 Million |
| 2010 | 14.37% | 4.17% | 1.10x | 3.13x | €27.61 Million |
| 2011 | 17.68% | 5.67% | 1.07x | 2.93x | €55.53 Million |
| 2012 | 19.20% | 5.83% | 1.13x | 2.92x | €66.31 Million |
| 2013 | 14.84% | 5.07% | 1.15x | 2.54x | €39.27 Million |
| 2014 | 11.69% | 4.29% | 1.09x | 2.50x | €15.12 Million |
| 2015 | 3.56% | 1.29% | 1.13x | 2.45x | €-60.86 Million |
| 2016 | 8.20% | 3.25% | 1.09x | 2.31x | €-18.07 Million |
| 2017 | 9.23% | 3.83% | 1.09x | 2.21x | €-8.24 Million |
| 2018 | 3.18% | 1.32% | 1.08x | 2.23x | €-73.57 Million |
| 2019 | 3.10% | 1.20% | 1.08x | 2.39x | €-74.13 Million |
| 2020 | 24.22% | 7.34% | 1.03x | 3.20x | €146.87 Million |
| 2021 | 12.24% | 4.63% | 1.05x | 2.52x | €28.24 Million |
| 2022 | -4.90% | -2.12% | 0.98x | 2.36x | €-196.37 Million |
| 2023 | 6.66% | 2.81% | 1.08x | 2.20x | €-46.96 Million |
| 2024 | 8.10% | 3.69% | 1.09x | 2.02x | €-29.11 Million |
Industry Comparison
This section compares Drägerwerk AG & Co. KGaA's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $934,837,026
- Average return on equity (ROE) among peers: -23.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Drägerwerk AG & Co. KGaA (DRW8) | €1.51 Billion | 17.05% | 1.01x | $831.47 Million |
| HeraMED Limited (1I4) | $2.59 Million | -168.10% | 0.60x | $26.40 Million |
| Medtronic PLC (2M6) | $841.50 Million | 23.43% | 0.53x | $102.18 Billion |
| Peijia Medical Limited (4WO) | $2.04 Billion | -11.08% | 0.32x | $403.65 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.22 Billion | -2.23% | 0.20x | $107.57 Million |
| MODULIGHT OY EO 1 (78W) | $44.68 Million | -10.30% | 0.10x | $43.97 Million |
| ACOTEC SCIEN.H. DL-00001 (7W3) | $1.28 Billion | 5.50% | 0.11x | $377.38 Million |
| LIFETECH SCI.DL-00000125 (81X) | $2.53 Billion | 11.56% | 0.26x | $893.41 Million |
| ORTOMA AB B (82Y) | $142.72 Million | -13.45% | 0.13x | $26.39 Million |
| COPLAND ROAD CAPITAL NEW (A2P) | $223.54 Million | 46.04% | 1.19x | $594.67 Million |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more